Breast Cancer
Findings from Greece, the United Kingdom and Tokyo in breast cancer provide new insights
Published in Women's Health Weekly, May 1st, 2006
Study 1: Metastatic breast cancer (MBC) could be treated by gemcitabine in combination with vinorelbine.
Researchers in Greece conducted a study "to evaluate the activity and toxicity of gemcitabine and vinorelbine in patients with MBC, previously treated with anthracyclines alone or with taxanes. A total of 86 pretreated patients with MBC (median age 62 years) entered the study. Thirty-six patients had been pretreated with anthracyclines and 8 were resistant."
"The combination of gemcitabine (1000 mg/m2) and vinorelbine (25...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Atherosclerosis
Atherosclerosis risk may be reduced by weight loss-induced changes in cathepsin S level - Breast Cancer
Breast cancer risk may be increased with lifetime moderate alcohol intake - Neurology
Migraine prevalence in women may be due to changes in endocannabinoid system - Osteoporosis
Bone mineral density may be improved by adding vitamin K2 to calcium supplementation - Pre-eclampsia
Pre-eclampsia severity, but not incidence, may be reduced with calcium supplementation - Acne
New free teen beauty guide keeps pimples away from the prom - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
